O'Brien P Q, Park J H, Johnson M A. "Method for the Synthesis of N-[(2-Chloro-1,3-thiazol-5-yl)methyl]-N-(cyclopropylmethyl)-1-propanamine" [P]. US Patent, US 9013450 B2, 2022-04-18.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2016, 1945, 3878-3905.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2025, 1627, 9356-9372.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of N-[(2-Chloro-1,3-thiazol-5-yl)methyl]-N-(cyclopropylmethyl)-1-propanamine Using HRMS and NMR". Chromatographia, 2012, 1360, (1), 6108-6116.
Kim S H, Park J Y. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2015, 381, 4990-5001.